Larvol Delta - Vaccine-Therapy-With-or-Without-PolysaccharideK-in-Patients-With-Stage-IV-HER2-Positive-Breast-Cancer-Receiving-HER2Targeted-Monoclonal-Antibody-Therapy

Trazimera (trastuzumab-qyyp) - Pfizer

AST-301 - University of Washington, Aston Sci., EpiThany

Perjeta (pertuzumab) - Roche

http://clinicaltrials.gov/ct2/show/NCT01922921

Apr 18, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next